sistance Act of 1961, as provided in section 706
of the Department of State Authorization Act
for Fiscal Year 2003, is warranted with respect
to countries the Director assesses have not co-
operated fully; and
‘‘(12) appoint a United States Interdiction Co-
ordinator under subsection (i).’’.
(f) UNITED STATES INTERDICTION COORDINATOR.—
Section 704 (21 U.S.C. 1703) is further amended by add-
ing at the end the following:
‘‘(i) 
UNITED
STATES
INTERDICTION
COORDI-
NATOR.—
‘‘(1) IN GENERAL.—There shall be in the Office
a United States Interdiction Coordinator, who shall
be appointed by the Director and shall perform du-
ties determined by the Director with respect to co-
ordination of efforts to interdict illicit drugs from
the United States.
‘‘(2) APPOINTMENT.—
‘‘(A) IN GENERAL.—Notwithstanding any
other provision of law (except subparagraph
(B)), the Director may appoint any individual
to serve as the United States Interdiction Coor-
dinator.
‘‘(B) LIMITATION.—The Director may not
appoint to such position any individual who
concurrently serves as the head of any other
Federal department or agency or any subdivi-
sion thereof with responsibility for narcotics
interdiction activities, except the counter-
narcotics officer of the Department of Home-
land Security appointed under section 878 of
the Homeland Security Act of 2002 (6 U.S.C.
458).’’.
(g) REQUIREMENT FOR SOUTH AMERICAN HEROIN
STRATEGY.—
(1) IN GENERAL.—Not later than 90 days after
the date of the enactment of this Act, the Director
of National Drug Control Policy shall submit to the
Congress a comprehensive strategy that addresses
the increased threat from South American heroin,
and in particular Colombian heroin.
(2) CONTENTS.—The strategy shall—
(A) include opium eradication efforts to
eliminate the problem at the source to prevent
it from reoccurring before the heroin enters the
stream of commerce;
(B) interdiction and precursor chemical
controls;
(C) demand reduction and treatment;
(D) provisions that ensure the mainte-
nance at current levels of efforts to eradicate
coca in Colombia; and
(E) assessment of the level of additional
funding and resources necessary to simulta-
neously address the threat from South Amer-
ican heroin and the threat from Colombian
coca.
SEC. 4. AMENDMENTS RELATING TO COORDINATION WITH
OTHER AGENCIES.
Section 705 (21 U.S.C. 1704) is amended—
(1) 
in 
subsection 
(a)(1)(A), 
by 
striking
‘‘abuse’’;
(2) by amending paragraph (3) of subsection
(a) to read as follows:
‘‘(3) REQUIRED REPORTS.—
‘‘(A) SECRETARIES OF THE INTERIOR AND
AGRICULTURE.—The Secretaries of Agriculture
and Interior shall, by July 1 of each year, joint-
ly submit to the Director and the authorizing
Committees of Congress for the Office an as-
sessment of the quantity of illegal drug cultiva-
tion and manufacturing in the United States on
lands owned or under the jurisdiction of the
Federal Government for the preceding year.
‘‘(B) ATTORNEY GENERAL.—The Attorney
General shall, by July 1 of each year, submit to
the Director and the authorizing Committees of
Congress for the Office information for the pre-
ceding year regarding the number and type
of—
‘‘(i) arrests for drug violations;
‘‘(ii) prosecutions for drug violations
by United States Attorneys; and
‘‘(iii) the number and type of seizures
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical
information on the geographic areas of
such seizures.
‘‘(C) SECRETARY
OF
HOMELAND
SECU-
RITY.—The Secretary of Homeland Security
shall, by July 1 of each year, submit to the Di-
rector and the authorizing Committees of Con-
gress for the Office information for the pre-
ceding year regarding—
‘‘(i) the number and type of seizures
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical
information on the geographic areas of
such seizures; and
‘‘(ii) the number of air and maritime
patrol hours undertaken by each compo-
nent of the Department primarily dedi-
cated to drug supply reduction missions.
‘‘(D) SECRETARY OF DEFENSE.—The Sec-
retary of Defense shall, by July 1 of each year,
submit to the Director and the authorizing
Committees of Congress for the Office informa-
tion for the preceding year regarding the num-
ber of air and maritime patrol hours primarily
dedicated to drug supply reduction missions un-
dertaken by each component of the Department
of Defense.’’; and
(3) in subsection (b)(2)(B), by striking ‘‘Pro-
gram.’’ and inserting ‘‘Strategy.’’.
SEC. 5. DEVELOPMENT, SUBMISSION, IMPLEMENTATION,
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY.
Section 706 (21 U.S.C. 1705) is amended to read as
follows:
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION,
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY.
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL-
OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL
STRATEGY.—
‘‘(1) IN GENERAL.—Not later than February 1
of each year, the President shall submit to Congress
a National Drug Control Strategy, which shall set
forth a comprehensive plan for reducing illicit drug
use and the consequences of illicit drug use in the
United States by reducing the demand for illegal
drugs, limiting the availability of illegal drugs, and
conducting law enforcement activities with respect to
illegal drugs.
‘‘(2) CONTENTS.—
‘‘(A) IN
GENERAL.—The National Drug
Control Strategy submitted under paragraph
(1) shall include—
‘‘(i) comprehensive, research-based,
long-range, and quantifiable goals for re-
ducing illicit drug use and the con-
sequences of illicit drug use in the United
States;
‘‘(ii) annual objectives and strategy
for demand reduction, supply reduction,
and law enforcement activities, specific tar-
gets to accomplish long-range quantifiable
reduction in illicit drug use as determined
by the Director, and specific measurements
to evaluate progress toward the targets
and strategic goals;
‘‘(iii) a strategy to reduce the avail-
ability and purity of illegal drugs and the
level of drug-related crime in the United
States;
‘‘(iv) an assessment of Federal effec-
tiveness in achieving the National Drug
Control Strategy for the previous year,
including—
‘‘(I) a specific evaluation of
whether the objectives and targets for
reducing illicit drug use for the pre-
vious year were met and reasons for
the success or failure of the previous
year’s Strategy; and
‘‘(II) an assessment of the avail-
ability and purity of illegal drugs and
the level of drug-related crime in the
United States;
‘‘(v) notification of any program or
budget priorities that the Director expects
to significantly change from the current
Strategy over the next five years;
‘‘(vi) a review of international, State,
local, and private sector drug control ac-
tivities to ensure that the United States
pursues well-coordinated and effective drug
control at all levels of government;
‘‘(vii) such statistical data and infor-
mation as the Director deems appropriate
to demonstrate and assess trends relating
to illicit drug use, the effects and con-
sequences thereof, supply reduction, de-
mand reduction, drug-related law enforce-
ment, and the implementation of the Na-
tional Drug Control Strategy; and
‘‘(viii) a supplement reviewing the ac-
tivities of each individual National Drug
Control Program agency during the pre-
vious year with respect to the National
Drug Control Strategy and the Director’s
assessment of the progress of each Na-
tional Drug Control Program agency in
meeting its responsibilities under the Na-
tional Drug Control Strategy.
‘‘(B) 
CLASSIFIED
INFORMATION.—Any
contents of the National Drug Control Strategy
that involve information properly classified
under criteria established by an Executive order
shall be presented to Congress separately from
the rest of the National Drug Control Strategy.
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for
inclusion under subparagraph (A), the Director
shall ensure—
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current
trends against previously compiled data
and information where the Director be-
lieves such analysis enhances long-term as-
sessment of the National Drug Control
Strategy; and
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of
drug treatment programs in the United
States.
‘‘(3) PROCESS FOR DEVELOPMENT AND SUB-
MISSION.—
‘‘(A) CONSULTATION.—In developing and
effectively implementing the National Drug
Control Strategy, the Director—
‘‘(i) shall consult with—
‘‘(I) the heads of the National
Drug Control Program agencies;
‘‘(II) Congress;
‘‘(III) State and local officials;
‘‘(IV) private citizens and organi-
zations with experience and expertise
in demand reduction;
‘‘(V) private citizens and organi-
zations with experience and expertise
in supply reduction;
‘‘(VI) private citizens and organi-
zations with experience and expertise
in law enforcement; and
‘‘(VII) appropriate representa-
tives of foreign governments;
‘‘(ii) with the concurrence of the At-
torney General, may require the El Paso
Intelligence Center to undertake specific
tasks or projects to implement the Na-
tional Drug Control Strategy;
‘‘(iii) with the concurrence of the Di-
rector of Central Intelligence and the At-
torney General, may request that the Na-
tional Drug Intelligence Center undertake
specific tasks or projects to implement the
National Drug Control Strategy; and
‘‘(iv) may make recommendations to
the Secretary of Health and Human Serv-
ices on research that supports or advances
the National Drug Control Strategy.
‘‘(B) RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include
recommendations of research to be performed
at the National Institutes of Health, including
the National Institute on Drug Abuse, or any
other appropriate agency within the Depart-
ment of Health and Human Services.
‘‘(C) INCLUSION IN STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
section shall include a list of each entity con-
sulted under subparagraph (A)(i).
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The
President may submit to Congress a revised Na-
tional Drug Control Strategy that meets the require-
ments of this section—
‘‘(A) at any time, upon a determination by
the President, in consultation with the Director,
that the National Drug Control Strategy in ef-
fect is not sufficiently effective; or
‘‘(B) if a new President or Director takes
office.
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not
later than February 1 of each year, the Director shall sub-
mit to Congress a description of the national drug control
performance measurement system, designed in consulta-
tion with affected National Drug Control Program agen-
cies, that includes performance measures for the National
Drug Control Strategy and activities of National Drug
Control Program agencies related to the National Drug
Control Strategy.’’.
SEC. 6. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM.
(a) IN GENERAL.—Section 707 (21 U.S.C. 1706) is
amended to read as follows:
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS
PROGRAM.
‘‘(a) ESTABLISHMENT.—There is established in the
Office a program to be known as the High Intensity Drug
Trafficking Areas Program (in this section referred to as
the ‘Program’).
‘‘(b) PURPOSES.—The purposes of the Program are
the following:
‘‘(1) To reduce drug availability and facilitate
cooperative efforts between Federal, State, and local
law enforcement agencies in areas with significant
drug trafficking problems that harmfully impact
other parts of the Nation.
‘‘(2) To provide assistance to agencies to come
together to assess regional threats, design coordi-
nated strategies to combat those threats, share intel-
ligence, and develop and implement coordinated ini-
tiatives to implement the strategies.
‘‘(c) DESIGNATION.—The Director, upon consulta-
tion with the Attorney General, the Secretary of the
Treasury, the Secretary of Homeland Security, heads of
the National Drug Control Program agencies, and the
Governor of each applicable State, may designate any
specified area of the United States as a high intensity
drug trafficking area.
‘‘(d) FACTORS FOR CONSIDERATION.—
‘‘(1) IN GENERAL.—In considering whether to
designate an area under this section as a high inten-
sity drug trafficking area, the Director shall con-
sider, in addition to such other criteria as the Direc-
tor considers to be appropriate, the extent to
which—
‘‘(A) the area is a major center of illegal
drug production, manufacturing, importation,
or distribution for the United States as com-
pared to other areas of the United States;
‘‘(B) State and local law enforcement
agencies have committed resources to respond
to the drug trafficking problem in the area,
thereby indicating a determination to respond
aggressively to the problem;
‘‘(C) drug production, manufacturing, im-
portation, or distribution in the area is having
a significant harmful impact in other areas of
the United States; and
‘‘(D) a significant increase in allocation of
Federal resources is necessary to respond ade-
quately to drug-related activities in the area.
‘‘(2) CONSIDERATIONS.—For purposes of para-
graph (1)(A), in considering whether an area is a
major center of illegal drug production, manufac-
turing, importation, or distribution as compared to
other areas of the United States, the Director shall
consider—
‘‘(A) the quantity of illicit drug traffic en-
tering or transiting the area originating in for-
eign countries;
‘‘(B) the quantity of illicit drugs produced
in the area;
‘‘(C) the number of Federal, State, and
local arrests, prosecutions, and convictions for
drug trafficking and distribution offenses in the
area;
‘‘(D) the degree to which the area is a cen-
ter for the activities of national drug trafficking
organizations; and
‘‘(E) such other criteria as the Director
considers appropriate.
‘‘(e) SOUTHWEST BORDER.—The Director may not
designate any county contiguous to the international land
border with Mexico as part of any high intensity drug traf-
ficking area other than as part of a single Southwest Bor-
der high intensity drug trafficking area.
‘‘(f) REMOVAL FROM DESIGNATION.—The Director
may remove an area or portion of an area from designa-
tion as a high intensity drug trafficking area under this
section upon determination that the area or portion of an
area no longer is a high intensity drug trafficking area,
considering the factors in subsections (d) and (e) in addi-
tion to such other criteria as the Director considers to be
appropriate.
‘‘(g) AUTHORITY OF THE DIRECTOR.—After making
such a designation and in order to provide Federal assist-
ance to the area so designated, the Director may—
‘‘(1) obligate such sums as appropriated for the
Program, in accordance with subsection (h);
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval
of the head of the department or agency that em-
ploys such personnel; and
‘‘(3) take any other action authorized under
section 704 to provide increased Federal assistance
to those areas.
‘‘(h) ALLOCATION OF FUNDING.—In obligating sums
appropriated for the Program, the Director shall comply
with the following:
‘‘(1) 30 PERCENT SET ASIDE.—The Director
shall expend no less than 30 percent of the amounts
appropriated under this section in the seven high in-
tensity drug trafficking areas (excluding the South-
west Border high intensity drug trafficking area) for
which the Director determines that Program activi-
ties with respect to such areas will have the greatest
impact on reducing overall drug traffic in the United
States.
‘‘(2) 25 PERCENT SET ASIDE.—The Director
shall expend no less than 25 percent of the amounts
appropriated under this section in nine other high
intensity drug trafficking areas (excluding the
Southwest Border high intensity drug trafficking
area) for which the Director determines that Pro-
gram activities with respect to such areas will have
the next greatest impact on reducing overall drug
traffic in the United States.
‘‘(3) SOUTHWEST BORDER AREA.—
‘‘(A) 20 PERCENT SET ASIDE.—The Direc-
tor shall expend no less than 20 percent of the
amounts appropriated under this section in the
Southwest Border high intensity drug traf-
ficking area.
‘‘(B) REALLOCATION WITHIN AREA.—The
executive committee of the Southwest Border
high intensity drug trafficking area may reallo-
cate up to five percent of the total funds allo-
cated to that area among its components, with
the approval of the Director.
‘‘(4) REMAINING
AREAS.—The Director shall
expend no less than 10 percent of the amounts ap-
propriated under this section in the remaining high
intensity drug trafficking areas.
‘‘(5) DISCRETIONARY EXPENDITURES.—
‘‘(A) IN
GENERAL.—In addition to the
amounts 
allocated 
under 
paragraphs 
(1)
through (4) the Director may expend 15 per-
cent of the amounts appropriated under this
section on a discretionary basis.
‘‘(B) CONSIDERATION OF IMPACT.—In al-
locating funds under this paragraph, the Direc-
tor shall consider—
‘‘(i) the impact of activities funded on
reducing overall drug traffic in the United
States;
‘‘(ii) performance measures of effec-
tiveness; and
‘‘(iii) such other criteria as the Direc-
tor considers appropriate.
‘‘(i) USE OF FUNDS.—
‘‘(1) LIMITATION.—No funds appropriated for
the Program shall be expended for drug treatment
programs.
‘‘(2) LIMITATION
ON
APPLICABILITY.—Para-
graph (1) shall not apply with respect to the
Baltimore/Washington high intensity drug traf-
ficking area.
‘‘(j) TERRORISM ACTIVITIES.—
‘‘(1) ASSISTANCE AUTHORIZED.—The Director
may authorize use of resources available for the Pro-
gram to assist Federal, State, and local law enforce-
ment agencies in investigations and activities related
to terrorism and prevention of terrorism, especially
but not exclusively where such investigations are re-
lated to drug trafficking.
‘‘(2) LIMITATION.—The Director shall ensure—
‘‘(A) that assistance provided under para-
graph (1) remains incidental to the purpose of
the Program to reduce drug availability and
carry out drug-related law enforcement activi-
ties; and
‘‘(B) that significant resources of the Pro-
gram are not redirected to activities exclusively
related to terrorism.
‘‘(k) BOARD REPRESENTATION.—None of the funds
appropriated under this section may be expended for any
high intensity drug trafficking area, or for a partnership
under the Program, if the executive board or equivalent
governing committee with respect to such area or partner-
ship is not comprised of equal voting representation be-
tween representatives of Federal law enforcement agencies
and representatives of State and local law enforcement
agencies.
‘‘(l) ROLE OF DRUG ENFORCEMENT ADMINISTRA-
TION.—The Director, in consultation with the Attorney
General, shall ensure that a representative of the Drug
Enforcement Administration is included in the Intelligence
Support Center for each high intensity drug trafficking
area.
‘‘(m) AUTHORIZATION OF APPROPRIATIONS.—There
is authorized to be appropriated to the Office of National
Drug Control Policy to carry out this section—
‘‘(1) $230,000,000 for fiscal year 2004;
‘‘(2) $240,000,000 for each of fiscal years 2005
and 2006; and
‘‘(3) $250,000,000 for each of fiscal years 2007
and 2008.’’.
(b) REVIEW OF CURRENT AREAS.—Within one year
after the date of enactment of this Act, the Director of
National Drug Control Policy shall—
(1) review each of the areas currently des-
ignated as a high intensity drug trafficking area to
determine whether it continues to warrant designa-
tion as a high intensity drug trafficking area, con-
sidering the factors in section 707(d) of the Office
of National Drug Control Policy Reauthorization Act
of 1998, as amended by this section, in addition to
such other criteria as the Director considers to be
appropriate; and
(2) terminate such description for an area or
portion of an area determined to no longer warrant
designation.
SEC. 7. FUNDING FOR CERTAIN HIGH INTENSITY DRUG
TRAFFICKING AREAS.
(a) SHORT TITLE.—This section may be cited as the
‘‘Dawson Family Community Protection Act’’.
(b) FINDINGS.—Congress finds the following:
(1) In the early morning hours of October 16,
2002, the home of Carnell and Angela Dawson was
firebombed 
in 
apparent 
retaliation 
for 
Mrs.
Dawson’s notification of police about persistent drug
distribution activity in their East Baltimore City
neighborhood.
(2) The arson claimed the lives of Mr. and Mrs.
Dawson and their 5 young children, aged 9 to 14.
(3) The horrific murder of the Dawson family
is a stark example of domestic narco-terrorism.
(4) In all phases of counter-narcotics law en-
forcement—from prevention to investigation to pros-
ecution to reentry—the voluntary cooperation of or-
dinary citizens is a critical component.
(5) Voluntary cooperation is difficult for law en-
forcement officials to obtain when citizens feel that
cooperation carries the risk of violent retaliation by
illegal drug trafficking organizations and their affili-
ates.
(6) Public confidence that law enforcement is
doing all it can to make communities safe is a pre-
requisite for voluntary cooperation among people
who may be subject to intimidation or reprisal (or
both).
(7) Witness protection programs are insufficient
on their own to provide security because many indi-
viduals and families who strive every day to make
distressed neighborhoods livable for their children,
other relatives, and neighbors will resist or refuse of-
fers of relocation by local, State, and Federal pros-
ecutorial agencies and because, moreover, the contin-
ued presence of strong individuals and families is
critical to preserving and strengthening the social
fabric in such communities.
(8) Where (as in certain sections of Baltimore
City) interstate trafficking of illegal drugs has severe
ancillary local consequences within areas designated
as high intensity drug trafficking areas, it is impor-
tant that supplementary High Intensity Drug Traf-
ficking Areas Program funds be committed to sup-
port initiatives aimed at making the affected com-
munities safe for the residents of those communities
and encouraging their cooperation with local, State,
and Federal law enforcement efforts to combat ille-
gal drug trafficking.
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG
TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706) is
further amended in subsection (h) by adding at the end
the following new paragraph:
‘‘(6) SPECIFIC PURPOSES.—
‘‘(A) IN GENERAL.—The Director shall en-
sure that, of the amounts appropriated for a
fiscal year for the Program, at least $1,000,000
is used in high intensity drug trafficking areas
with severe neighborhood safety and illegal drug
distribution problems.
‘‘(B) REQUIRED
USES.—The funds used
under subparagraph (A) shall be used—
‘‘(i) to ensure the safety of neighbor-
hoods and the protection of communities,
including the prevention of the intimida-
tion of potential witnesses of illegal drug
distribution and related activities; and
‘‘(ii) to combat illegal drug trafficking
through such methods as the Director con-
siders appropriate, such as establishing or
operating (or both) a toll-free telephone
hotline for use by the public to provide in-
formation about illegal drug-related activi-
ties.’’.
SEC. 8. AMENDMENTS RELATING TO COUNTER-DRUG TECH-
NOLOGY ASSESSMENT CENTER.
(a) CHIEF SCIENTIST.—Section 708(b) (21 U.S.C.
1707(b)) is amended—
(1) in the heading by striking ‘‘DIRECTOR OF
TECHNOLOGY.—’’ 
and 
inserting 
‘‘CHIEF
SCI-
ENTIST.—’’; and
(2) by striking ‘‘Director of Technology,’’ and
inserting ‘‘Chief Scientist,’’.
(b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.—
Section 708(c) (21 U.S.C. 1707(c)) is amended to read
as follows:
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC-
TOR OF NATIONAL DRUG CONTROL POLICY.—
‘‘(1) 
IN
GENERAL.—The 
Director, 
acting
through the Chief Scientist shall—
‘‘(A) identify and define the short-, me-
dium-, and long-term scientific and techno-
logical needs of Federal, State, and local law
enforcement agencies relating to drug enforce-
ment, including—
‘‘(i) advanced surveillance, tracking,
and radar imaging;
‘‘(ii) electronic support measures;
‘‘(iii) communications;
‘‘(iv) data fusion, advanced computer
systems, and artificial intelligence; and
‘‘(v) chemical, biological, radiological
(including neutron, electron, and graviton),
and other means of detection;
‘‘(B) identify demand reduction (including
drug prevention) basic and applied research
needs and initiatives, in consultation with af-
fected National Drug Control Program agen-
cies, including—
‘‘(i) improving treatment through
neuroscientific advances;
‘‘(ii) improving the transfer of bio-
medical research to the clinical setting; and
‘‘(iii) in consultation with the Na-
tional Institute on Drug Abuse and the
Substance Abuse and Mental Health Serv-
ices Administration, and through inter-
agency agreements or grants, examining
addiction and rehabilitation research and
the application of technology to expanding
the effectiveness or availability of drug
treatment;
‘‘(C) make a priority ranking of such needs
identified in subparagraphs (A) and (B) accord-
ing to fiscal and technological feasibility, as
part of a National Counter-Drug Enforcement
Research and Development Program;
‘‘(D) oversee and coordinate counter-drug
technology initiatives with related activities of
other Federal civilian and military departments;
‘‘(E) oversee and coordinate a technology
transfer program for the transfer of technology
to State and local law enforcement agencies;
and
‘‘(F) pursuant to the authority of the Di-
rector of National Drug Control Policy under
section 704, submit requests to Congress for
the reprogramming or transfer of funds appro-
priated for counter-drug technology research
and development.
‘‘(2) PRIORITIES
IN
TRANSFERRING
TECH-
NOLOGY.—In transferring technology under the au-
thority of paragraph (1)(E), the Chief Scientist shall
give priority, in transferring technologies most likely
to assist in drug interdiction and border enforce-
ment, to State, local, and tribal law enforcement
agencies in southwest border areas and northern
border areas with significant traffic in illicit drugs.
‘‘(3) LIMITATION ON AUTHORITY.—The author-
ity granted to the Director under this subsection
shall not extend to the award of contracts, manage-
ment of individual projects, or other operational ac-
tivities.’’.
(c) ASSISTANCE FROM SECRETARY OF HOMELAND
SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is
amended by inserting ‘‘, the Secretary of Homeland Secu-
rity,’’ after ‘‘The Secretary of Defense’’.
SEC. 9. REPEALS.
The following provisions are repealed:
(1) Sections 709 and 711 (21 U.S.C. 1708 and
1710).
(2) Section 6073 of the Asset Forfeiture
Amendments Act of 1988 (21 U.S.C. 1509).
SEC. 10. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN.
(a) IN GENERAL.—The Act is further amended by
inserting after section 708 the following:
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN.
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional media campaign in accordance with this section for
the purpose of reducing and preventing illicit drug use
among young people in the United States, through mass
media advertising.
‘‘(b) USE OF FUNDS.—
‘‘(1) IN GENERAL.—Amounts made available to
carry out this section for the media campaign may
only be used for the following:
‘‘(A) The purchase of media time and
space.
‘‘(B) Creative and talent costs.
‘‘(C) Advertising production costs.
‘‘(D) Testing and evaluation of advertising.
‘‘(E) Evaluation of the effectiveness of the
media campaign.
‘‘(F) The negotiated fees for the winning
bidder on requests for proposals issued either
by the Office or its designee for purposes other-
wise authorized in this section.
‘‘(G) Partnerships with community, civic,
and professional groups and government organi-
zations related to the media campaign.
‘‘(H) Entertainment industry outreach,
interactive outreach, media projects and activi-
ties, public information, news media outreach,
and corporate sponsorship and participation.
‘‘(I) Operational and management ex-
penses.
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for creative and
talent costs under paragraph (1)(B), the
Director shall use creative services donated
at no cost to the Government wherever fea-
sible and may only procure creative serv-
ices for advertising—
‘‘(I) responding to high-priority
or emergent campaign needs that can-
not timely be obtained at no cost; or
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience
that cannot reasonably be obtained at
no cost.
‘‘(ii) No more than $1,000,000 may
be expended under this section each fiscal
year on creative services, except that the
Director may expend up to $2,000,000 in
a fiscal year on creative services to meet
urgent needs of the media campaign with
advance approval from the Committee on
Appropriations of the House of Represent-
atives and of the Senate upon a showing of
the circumstances causing such urgent
needs of the media campaign.
‘‘(B) TESTING AND EVALUATION OF AD-
VERTISING.—In using amounts for testing and
evaluation of advertising under paragraph
(1)(D), the Director shall test all advertise-
ments prior to use in the media campaign to
ensure that the advertisements are effective and
meet industry-accepted standards. The Director
may waive this requirement for advertisements
using no more than 10 percent of the purchase
of advertising time purchased under this section
in an fiscal year and no more than 10 percent
of the advertising space purchased under this
section in a fiscal year, if the advertisements re-
spond to emergent and time-sensitive campaign
needs or the advertisements will not be widely
utilized in the media campaign.
‘‘(C) EVALUATION OF EFFECTIVENESS OF
MEDIA CAMPAIGN.—In using amounts for the
evaluation of the effectiveness of the media
campaign under paragraph (1)(E), the Director
shall—
‘‘(i) designate an independent entity
to evaluate annually the effectiveness of
the national media campaign based on
data from—
‘‘(I) the ‘Monitoring the Future
Study’ published by the Department
of Health and Human Services;
‘‘(II) 
the 
Attitude 
Tracking
Study published by the Partnership
for a Drug Free America;
‘‘(III) the National Household
Survey on Drug Abuse; and
‘‘(IV) other relevant studies or
publications, as determined by the Di-
rector, including tracking and evalua-
tion data collected according to mar-
keting and advertising industry stand-
ards; and
‘‘(ii) ensure that the effectiveness of
the media campaign is evaluated in a man-
ner that enables consideration of whether
the media campaign has contributed to re-
duction of illicit drug use among youth and
such other measures of evaluation as the
Director determines are appropriate.
‘‘(3) PURCHASE
OF
ADVERTISING
TIME
AND
SPACE.—For each fiscal year, not less than 77 per-
cent of the amounts appropriated under this section
shall be used for the purchase of advertising time
and space for the media campaign, subject to the
following exceptions:
‘‘(A) In any fiscal year for which less than
$125,000,000 is appropriated for the media
campaign, not less than 82 percent of the
amounts appropriated under this section shall
be used for the purchase of advertising time
and space for the media campaign.
‘‘(B) In any fiscal year for which more
than $195,000,000 is appropriated under this
section, not less than 72 percent shall be used
for advertising production costs and the pur-
chase of advertising time and space for the
media campaign.
‘‘(c) ADVERTISING.—In carrying out this section, the
Director shall devote sufficient funds to the advertising
portion of the national media campaign to meet the goals
of the campaign.
‘‘(d) PROHIBITIONS.—None of the amounts made
available under subsection (b) may be obligated or ex-
pended for any of the following:
‘‘(1) To supplant current antidrug community-
based coalitions.
‘‘(2) To supplant pro bono public service time
donated by national and local broadcasting networks
for other public service campaigns.
‘‘(3) For partisan political purposes, or express
advocacy in support of or to defeat any clearly iden-
tified candidate, clearly identified ballot initiative, or
clearly identified legislative or regulatory proposal.
‘‘(4) To fund advertising that features any
elected officials, persons seeking elected office, cabi-
net level officials, or other Federal officials employed
pursuant to section 213 of Schedule C of title 5,
Code of Federal Regulations.
‘‘(5) To fund advertising that does not contain
a primary message intended to reduce or prevent il-
licit drug use.
‘‘(6) To fund advertising containing a primary
message intended to promote support for the media
campaign or private sector contributions to the
media campaign.
‘‘(e) MATCHING REQUIREMENT.—
‘‘(1) IN
GENERAL.—Amounts made available
under subsection (b) shall be matched by an equal
amount of non-Federal funds for the media cam-
paign, or be matched with in-kind contributions of
the same value.
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse
prevention consistent with the specific purposes of
the media campaign, except that in any fiscal year
in which less than $125,000,000 is appropriated to
the media campaign, the Director shall ensure that
at least 85 percent of no-cost match advertising di-
rectly relates to substance abuse prevention con-
sistent with the specific purposes of the media cam-
paign.
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY RELATED.—The Director shall ensure that
no-cost match advertising that does not directly re-
late to substance abuse prevention includes a clear
antidrug message. Such message is not required to
be the primary message of the match advertising.
‘‘(f) FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed—
‘‘(1) audits and reviews of costs of the media
campaign pursuant to section 304C of the Federal
Property and Administrative Services Act of 1949
(41 U.S.C. 254d); and
‘‘(2) an audit of the cost of the media campaign
described in section 306 of such Act (41 U.S.C.
256).
‘‘(g) STRATEGIC GUIDANCE AND DONATIONS.—The
Partnership for a Drug Free America shall serve as the
primary outside strategic advisor to the media campaign
and be responsible for coordinating donations of creative
and other services to the campaign, except with respect
to advertising created using funds permitted in subsection
(b). The Director shall inform the Partnership for a Drug
Free America of the strategic goals of the campaign and
consider advice from the Partnership for a Drug Free
America on media campaign strategy.
‘‘(h) REPORT
TO CONGRESS.—The Director shall
submit on an annual basis a report to Congress that
describes—
‘‘(1) the strategy of the media campaign and
whether specific objectives of the media campaign
were accomplished;
‘‘(2) steps taken to ensure that the media cam-
paign operates in an effective and efficient manner
consistent with the overall strategy and focus of the
media campaign;
‘‘(3) plans to purchase advertising time and
space;
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the
potential for waste, fraud, and abuse; and
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of
the media campaign.
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director
shall, to the maximum extent feasible, use amounts made
available under this section for media that focuses on, or
includes specific information on, prevention or treatment
resources for consumers within specific local areas.
‘‘(j) PREVENTION OF MARIJUANA USE.—
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing:
‘‘(A) 60 percent of adolescent admissions
for drug treatment are based on marijuana use.
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past,
rising from under 1 percent of THC in the mid-
1970s to as high as 30 percent today.
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early
in life may be up to five times more likely to
use hard drugs.
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent
educational achievement resulting from mari-
juana use.
‘‘(E) Contemporary research has dem-
onstrated clear detrimental effects in adolescent
brain development resulting from marijuana
use.
‘‘(F) An estimated 9,000,000 Americans a
year drive while under the influence of illegal
drugs, including marijuana.
‘‘(G) Marijuana smoke contains 50 to 70
percent more of certain cancer causing chemi-
cals than tobacco smoke.